Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

American Journal of Pathology

Volumn 155, Issue 4, 1999, Pages 1253-1260

  Perren, Aurel ^a,b,c   Weng, Liang Ping ^a   Boag, Alexander H ^d   Ziebold, Ulricke ^e   Thakore, Kosha ^a,b   Dahia, Patricia L M ^a,b   Komminoth, Paul ^c   Lees, Jacqueline A ^e   Mulligan, Lois M ^d   Mutter, George L ^f   Eng, Charis ^a,g  

^a OHIO STATE UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d QUEEN S UNIVERSITY   (Canada)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MYOEPITHELIUM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0032857217     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65227-3     Document Type: Article

References (28)

1. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittman M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947
2. Li D-M, Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor B. Cancer Res 1997, 57:2124-2129
3. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Mattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV: Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15:356-362
4. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997, 16:64-67
5. Eng C, Peacocke M, PTEN and inherited hamartoma-cancer syndromes. Nat Genet 1998, 19:223
6. Levine RL, Cargile CB, Blazes MS, van Rees B, Kurman RJ, Ellenson LH: PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 1998, 58:3254-3258
7. Maxwell GL, Risinger JL, Gumbs C, Shaw H, Bentley RC, Barrett JC, Berchuck A, Futreal PA: Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 1998, 58:2500-2503
8. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997, 57:3935-3940
9. Kong D, Suzuki A, Zou T-T, Sakurada A, Kemp LW, Wakatsuki S, Yokohama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Want S, Abraham JM, Souza RF, Smolinksi KN, Meltzer SJ, Horii A: PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 1997, 17:143-144
10. Maier D, Zhang ZW, Taylor E, Hamou MF, Gratzl O, van Meir EG, Scott RJ, Merlo A: Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene 1998, 16:3331-3335
11. Bose S, Wang SI, Terry MB, Hibshoosh H, Parsons R: Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene 1998, 17:123-127
12. Singh B, Ittman MM, Krolewski JJ: Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer 1998, 21:166-171
13. Feilotter HE, Coulon V, McVeigh JL, Boag AH, Donon-Bonnet F, Duboué B, Latham WCW, Eng C, Mulligan LM, Longy M: Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Br J Cancer 1999, 79:718-723
14. Dürr E-M, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Deimling A: PTEN mutations in gliomas and glioneuronal tumors. Oncogene 1998, 16:2259-2264
15. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997, 57:4183-4186
16. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 1997, 37: 4187-4190
17. Boström J, LudwigCobbers JMJ, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP, Reifenberger G: Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 1998, 58:29-33
18. Tsao HS, Zhang X, Benoit E, Haluska FG: Identification of PTEN/ MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 1998, 16:3397-3402
19. Rhei E, Kang L, Bogomoliniy F, Federici MG, Borgen PI, Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/ MMAC1 in primary breast carcinomas. Cancer Res 1997, 57:3657-3659
20. Starink TM, van der Veen JPW, Arwert F, de Waal LP, de Lange GG, Gille JJP, Eriksson AW: The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986, 29:222-233
21. Eng C: Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol 1998, 12:701-710
22. Eng C, Thomas GA, Neuberg DS, Mulligan LM, Healey CS, Houghton C, Frilling A, Raue F, Williams ED, Ponder BAJ: Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 1998, 83:4310-4313
23. Komminoth P, Roth J, Schroder S, Saremaiani P, Heitz PU: Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adenocortical carcinomas. Lab Invest 1995, 72:424-431
24. Heitz PU, Kasper M, Polak JM, Kloppel G: Pancreatic endocrine tumors. Hum Pathol 1982, 13:263-271
25. Werner M, von Wasiekewski R, Komminoth P: Antigen retrieval, signal amplification and intensification in immunohistochemistry. Histochem Cell Biol 1996, 105:253-260
26. Dahia PLM, Aguiar RCT, Alberta J, Kum J, Caron S, Sills H, Marsh DJM, Freedman A, Ritz J, Stiles C, Eng C: PTEN is inversely correlated with the cell survival factor PKB/Akt and is inactivated by diverse mechanisms in haematologic malignancies. Hum Mol Genet 1999, in press
27. Dahia PLM, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C: Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 1997, 57:4710-4713
28. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL: Inactivation of the tumor suppressor PTEN/ MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 1998, 95:5246-5250